MetaCap

Aktis Oncology (AKTS) News

NASDAQ: AKTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

16.15-0.25 (-1.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AKTS news summary

We found 2 recent headlines mentioning Aktis Oncology (AKTS): 0 in the past week and 2 in the past 30 days, most often from Seeking Alpha, GlobeNewswire. For price context, AKTS is down 1.52% at $16.15. The most recent story, "Aktis Oncology reports Q3 results", was published by Seeking Alpha on Nov 12, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Aktis Oncology headlines

Compare AKTS